Zhejiang Dayang Biotech Group Co Ltd
SZSE:003017
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (1.9), the stock would be worth ¥24.42 (23% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2.4 | ¥31.78 |
0%
|
| 3-Year Average | 1.9 | ¥24.42 |
-23%
|
| 5-Year Average | 2 | ¥25.58 |
-20%
|
| Industry Average | 2.5 | ¥32.01 |
+1%
|
| Country Average | 2.4 | ¥31.99 |
+1%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
Z
|
Zhejiang Dayang Biotech Group Co Ltd
SZSE:003017
|
2.7B CNY | 2.4 | 27.3 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
13.3T JPY | 3.1 | 27.3 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
78.7B USD | 17.1 | 30.7 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
72.4B USD | 7.4 | 34.9 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 0.7 | 10.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
282.8B CNY | 2.6 | 21.5 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
25.9B CHF | 5.7 | 24.1 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 11.8 | 54.8 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.4T INR | 12 | 60.9 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
23.4B USD | 2.9 | 14.8 | |
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR | 2.7 | 17.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.4 |
| 70th Percentile | 3.9 |
| Max | 1 172 445.9 |
Other Multiples
Zhejiang Dayang Biotech Group Co Ltd
Glance View
Zhejiang Dayang Biotech Group Co., Ltd. engages in the production and sales of potassium salt and veterinary drugs. The company is headquartered in Hangzhou, Zhejiang and currently employs 925 full-time employees. The company went IPO on 2020-10-26. The firm's main products include potassium carbonate, potassium bicarbonate, amproline hydrochloride, 2-chloro-6-fluorobenzaldehyde, etc. Its products are used in food, pesticide, fertilizer, medicine and glass fields. The firm conducts its businesses within the Chinese market and to overseas markets.
